The goal is to have a network of collaborations around the world so scientists can work together and share expertise and information to rapidly respond to new developments in the SARS-CoV-2 pandemic and to future emerging or re-emerging pathogen outbreaks. for sequencing, but also providing equipment, supplies and training to these South American institutions for scientists to follow COVID-19 in their countries. This includes shipping some samples to the U.S. The scientists met with doctors and researchers at hospitals in Peru and Bolivia to provide support for studying SARS-CoV-2 variants in their regions. This leads to huge disparities in knowledge of what is circulating in different parts of the globe.” “Compare that to North America or Europe where a vast majority of sequences are being provided. “If you look at the global public repository of all SARS-CoV-2 sequences, less than 1% come from the continent of Africa and less than 2% come from South America,” said Ozer, director of the CPGME. Their team has previously worked with collaborators in Africa - in the countries of Nigeria, Mali and Guinea - to sequence hundreds of COVID-19 specimens from undersampled regions.
The team has been studying the virus in Chicago and globally since the start of the pandemic. Lorenzo-Redondo and Ozer are part of a team at the Center for Pathogen Genomics and Microbial Evolution (CPGME), which is part of the Havey Institute for Global Health. They want to help build capacity for South American scientists and public health experts to conduct local investigations.
Havey, MD, Institute for Global Health to expand the global network of SARS-CoV-2 sequencing in regions where there is low or almost nonexistent viral genetic information reporting. The scientists’ travels through South America, which also included Lima, Peru, and Santa Cruz, Bolivia, are an effort by Northwestern University’s Robert J. Peru also has had the highest COVID-19 mortality rate during the entire pandemic, especially due to very high mortality observed during the first phases of the SARS-CoV-2 expansion. The reason for the recent trip? Iquitos had a high incidence of COVID-19 at the start of the pandemic, and they wanted to understand how the large city’s relative isolation affected the spread of viral variants in the region. They wanted to meet with clinicians and scientists who provide care to the surrounding communities along the Amazon River. Egon Ozer recently flew into Iquitos, a remote Peruvian city in the depths of the Amazon jungle accessible only by plane or river boat. Northwestern Medicine scientists Ramon Lorenzo-Redondo and Dr.
0 kommentar(er)
